Autophagy in hypertensive heart disease

Zhao V Wang1, Beverly A Rothermel, Joseph A Hill

  • 1Department of Medicine (Cardiology), University of Texas Southwestern Medical Center, Dallas, Texas 75390-8573, USA.

Insights

Hypertension causes heart growth, but too much autophagy, a cellular recycling process, can lead to heart failure. Understanding this balance is key to treating heart disease.

Area of Science:

  • Cardiovascular Biology
  • Cellular Biology
  • Molecular Medicine

Background:

  • Hypertension triggers cardiac hypertrophy, a compensatory growth response to increased wall stress.
  • Sustained cardiac hypertrophy is a significant risk factor for systolic dysfunction and heart failure.
  • The precise mechanisms driving the transition from hypertrophy to heart failure remain incompletely understood.

Purpose of the Study:

  • To investigate the role of autophagy in the progression of hypertension-induced cardiac hypertrophy.
  • To elucidate how dysregulated autophagy contributes to the development of heart failure.

Main Methods:

  • Analysis of autophagy markers in cardiac tissue under hypertensive conditions.
  • Investigation of the impact of modulating autophagy on cardiac function in experimental models.

Main Results:

  • Autophagy is activated during ventricular hypertrophy, playing a role in maintaining cellular homeostasis.
  • Excessive autophagy leads to the degradation of essential cellular components.
  • Overactive autophagy is associated with cell death and contributes to hypertension-related heart disease.

Conclusions:

  • Autophagy is a critical cellular process implicated in hypertension-related heart disease.
  • While initially protective, excessive autophagy can promote cardiac dysfunction and failure.
  • Targeting autophagy modulation may offer a therapeutic strategy for preventing or treating heart failure in hypertensive patients.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...